Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-006682
Filing Date
2025-03-04
Accepted
2025-03-04 18:14:13
Documents
1
Period of Report
2025-03-04

Document Format Files

Seq Description Document Type Size
1 form4-03042025_110310.html 4  
1 form4-03042025_110310.xml 4 3299
  Complete submission text file 0001415889-25-006682.txt   4994
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Issuer) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AADI BIOSCIENCE, INC. 17383 SUNSET AVENUE, SUITE A250 PACIFIC PALISADES CA 90272
Business Address
Zhao Baiteng (Reporting) CIK: 0002049287 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38560 | Film No.: 25707214